Perspective Therapeutics Inc’s filing revealed that its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0 on Mar 28 ’25. In the deal valued at $2.24 per share,22,026 shares were bought. As a result of this transaction, Spoor Johan M. now holds 59,383 shares worth roughly $0.13 million.
Then, Spoor Johan M. bought 4,650 shares, generating $10,288 in total proceeds. Upon buying the shares at $2.21, the Chief Executive Officer now owns 4,650 shares.
Before that, Williamson Robert F III bought 38,145 shares. Perspective Therapeutics Inc shares valued at $81,775 were divested by the Director at a price of $2.14 per share. As a result of the transaction, Williamson Robert F III now holds 108,982 shares, worth roughly $0.24 million.
H.C. Wainwright initiated its Perspective Therapeutics Inc [CATX] rating to a Buy in a research note published on March 13, 2025; the price target was $10. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early March with a ‘”a Sector outperform”‘ rating. BofA Securities also remained covering CATX and has decreased its forecast on November 25, 2024 with a “Neutral” recommendation from previously “Buy” rating. UBS started covering the stock on October 24, 2024. It rated CATX as “a Buy”.
Price Performance Review of CATX
On Tuesday, Perspective Therapeutics Inc [AMEX:CATX] saw its stock fall -7.82% to $2.24. Over the last five days, the stock has lost -7.05%. Perspective Therapeutics Inc shares have fallen nearly -29.78% since the year began. Nevertheless, the stocks have fallen -87.05% over the past one year. While a 52-week high of $19.05 was reached on 01/24/25, a 52-week low of $1.60 was recorded on 04/09/25. SMA at 50 days reached $2.32, while 200 days put it at $7.28.
Levels Of Support And Resistance For CATX Stock
The 24-hour chart illustrates a support level at 2.15, which if violated will result in even more drops to 2.05. On the upside, there is a resistance level at 2.37. A further resistance level may holdings at 2.49. The Relative Strength Index (RSI) on the 14-day chart is 48.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.49%. Stochastics %K at 73.41% indicates the stock is a holding.
The most recent change occurred on October 01, 2024 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $25 price target.
